HIV & AIDS

UNL team explores new approach to HIV vaccine

Using a genetically modified form of the HIV virus, a team of University of Nebraska-Lincoln scientists has developed a promising new approach that could someday lead to a more effective HIV vaccine.

Medications

Researchers pursuing powdered nasal vaccine against West Nile

Riding the expansion of mosquito-borne diseases from the tropics as temperatures rise across the globe, the West Nile Virus made its American landfall in New York about 15 years ago. Since then, it has spread throughout ...

HIV & AIDS

Durable end to AIDS will require HIV vaccine development

Broader global access to lifesaving antiretroviral therapies and wider implementation of proven HIV prevention strategies could potentially control and perhaps end the HIV/AIDS pandemic. However, a safe and at least moderately ...

HIV & AIDS

Experimental HIV vaccine targets virus envelope protein

AIDS research has investigated many strategies to tackle the HIV virus. Now, a new type of vaccine developed within the EU-funded project EuroNeut-41, targets an HIV envelope protein called the gp41. The protein is directly ...

page 28 from 35